(2026). A novel mRNA-based multiepitope vaccine candidate against Cryptosporidium hominis and Cryptosporidium parvum employing reverse-vaccinology and immunoinformatics approaches. PLOS ONE.
Successfully copied to clipboard
Copying to clipboard failed
Chicago Style (17th ed.) Citation
"A Novel MRNA-based Multiepitope Vaccine Candidate Against Cryptosporidium Hominis and Cryptosporidium Parvum Employing Reverse-vaccinology and Immunoinformatics Approaches."
PLOS ONE 2026.
Successfully copied to clipboard
Copying to clipboard failed
MLA (9th ed.) Citation
"A Novel MRNA-based Multiepitope Vaccine Candidate Against Cryptosporidium Hominis and Cryptosporidium Parvum Employing Reverse-vaccinology and Immunoinformatics Approaches."
PLOS ONE, 2026.
Successfully copied to clipboard
Copying to clipboard failed
Warning: These citations may not always be 100% accurate.